Background Trends of de novo implantation of cardiac implantable electronic devices
(CIEDs) including implantable cardioverter‐defibrillator (ICD) and cardiac resynchronization …

Background Elderly patients are underrepresented in clinical trials of device therapy.
Objective To provide real-world data regarding outcomes associated with device-based …

BACKGROUND: Because sudden cardiac death increases with age, implantable
cardioverter-defibrillators (ICDs) might greatly benefit the elderly. However, elderly patients …

Aims Currently, there continues to be a lack of evidence regarding outcomes associated with
device-based therapy for ventricular arrhythmias in elderly patients, even more in primary …

Background Registry data add important information to randomized controlled trials (RCT)
on real‐life aspects of implantable cardioverter‐defibrillator (ICD) patients with and without …

Abstract Background Implantable cardioverter-defibrillators (ICDs) and cardiac
resynchronization therapy (CRT) reduce sudden cardiac death and all-cause mortality in …

Background: Implantable cardioverter‐defibrillators (ICDs) reduce the rate of sudden cardiac
death (SCD) in patients with cardiomyopathy and reduced left ventricular systolic function. It …

Aims Limited data exist on outcomes in very elderly ICD recipients. We describe outcomes in
new ICD and Cardiac Resynchronisation Therapy with Defibrillator (CRT-D) implants in …

Background Large randomized trials demonstrated the beneficial effect of implantable
cardioverter-defibrillator (ICD) and cardiac resynchronization therapy–defibrillator (CRT-D) …

Implantable cardioverter–defibrillator (ICD) therapy decreases arrhythmic and all-cause
mortality in patients at high risk of sudden death. However, its clinical benefit in elderly …